Walleye Trading’s Agile Therapeutics AGRX Stock Holding History

Walleye Trading’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1	Closed	-$7K	–	5833
2015 Q3	$7K	Buy	+1	New	+$17.8K	﹤0.01%	4535
2015 Q2	–	Hold	0	–	–	–	4636

Other funds holding AGRX

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Walleye Trading's AGRX Position: Q4 2015 in Review

Walleye Trading sold out of Agile Therapeutics (AGRX) in Q4 2015, closing a stake of 1 share — an estimated $7K sold.

Walleye Trading first reported a position in AGRX in Q3 2015 and held it in 1 quarter. The position peaked at $7K in Q3 2015. 45 funds tracked by Wall St. Rank hold AGRX as of Q4 2015.

Walleye Trading reported no remaining Agile Therapeutics position as of Q4 2015 after selling out during the quarter.
Walleye Trading sold 1 Agile Therapeutics share in Q4 2015, an estimated $7K.
Walleye Trading first reported a position in Agile Therapeutics in Q3 2015 and held it in 1 quarter.
Walleye Trading's Agile Therapeutics position peaked at $7K in Q3 2015.
45 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2015.

Based on Walleye Trading's 13F filing for Q4 2015, filed 16 Feb 2016.